Advertisement

Pharmacy World & Science

, Volume 30, Issue 3, pp 243–250 | Cite as

Medicine-taking behaviour and drug-related problems in adolescents of a Swedish high school

  • Michael Westerlund
  • Jan-Olof Brånstad
  • Tommy WesterlundEmail author
Research Article

Abstract

Objectives To examine (1) which over-the-counter (OTC) and prescription drugs adolescents most frequently use and for which ailments or diseases, and (2) which DRPs adolescents have experienced, as well as if and by whom these problems were resolved. Setting A high school in Helsingborg, Sweden. Methods A self-completion questionnaire was designed and used in students with a median age of 17 in late 2005 and early 2006. To enable students to identify DRPs they may have experienced, the questionnaire contained a list of DRPs in lay language. The questionnaires were distributed by the teachers to be completed by the students in the classroom. Main outcome measures: Self-reported prevalence of OTC and prescription drug use and experienced drug-related problems. Results A total of 245 students (99%) took part, 138 females and 107 males. OTCs had been used occasionally by 37.7% of the girls and 62.6% of the boys, while 10.9% and 6.5% respectively were daily users. Analgesics were the most frequently used OTCs. DRPs had been experienced by 31.1% of the female and 19.6% of the male students, the most common of which was therapy failure (too little or no effect), accounting for 46.5% of the girls’ and 38.1% of the boys’ OTC DRPs. Eighty-five percent of the problems with OTCs had been resolved, half of them by the teenagers themselves. Prescription drugs had been used occasionally by 31.9% of the female and 29.0% of the male students, while 28.3% and 26.2% respectively reported using such drugs on a daily basis. Antibiotics were the most frequently taken prescription drugs. DRPs related to prescribed drugs were reported by 32.6% of the girls and 10.3% of the boys. The most common DRPs were side effects, accounting for 34.8% of the girls’ problems, and therapy failure, experienced by 28.6% of the boys. All the boys’ DRPs were reported to be resolved, but only 75% of those of the girls. Physicians were stated to have resolved the problems in 41.4% of the cases. Conclusions There is a need to develop the interface between pharmacy practitioners and adolescents, as the study has demonstrated frequent use of OTCs and prescription drugs as well as a high prevalence of DRPs in adolescents. The reasons for therapy failure, which was the most common problem, should be further explored and measures taken by pharmacists and physicians to minimise it.

Keywords

Adolescents Drug-related problems Medicine-taking behaviour OTCs prescription drugs Sweden 

Notes

Acknowledgements

We would like to thank the students and teachers of the Olympiaskolan in Helsingborg, Sweden, who made this study possible, and in particular the teacher Ms Anna Petersson for her kind assistance.

Funding

The study was funded by Olympiaskolan, Helsingborg, Sweden.

References

  1. 1.
    Holstein BE, Holme Hansen E, Due P, Almarsdottir AB. Self-reported medicine use among 11- to 15-year old girls and boys in Denmark 1988–1998. Scand J Public Health 2003;31(5):334–41.PubMedCrossRefGoogle Scholar
  2. 2.
    Hansen EH, Holstein BE, Due P, Currie CE. International survey of self-reported medicine use among adolescents. Ann Pharmacother 2003;37:361–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Stoelben S, Krappweis J, Rossler G, Kirch W. Adolescents’ drug use and drug knowledge. Eur J Pediatr 2000;159(8):608–14.PubMedCrossRefGoogle Scholar
  4. 4.
    Van den Bulck J, Leemans L, Laekeman GM. Television and adolescent use of over-the-counter analgesic agents. Ann Pharmacother 2005;39:58–62.PubMedGoogle Scholar
  5. 5.
    Campbell MA, McGrath PJ. Use of medication by adolescents for the management of menstrual discomfort. Arch Pediatr Adolesc Med 1997;151(9):905–13.PubMedGoogle Scholar
  6. 6.
    Huott MA, Storrow AB. A survey of adolescents’ knowledge regarding toxicity of over-the-counter medications. Acad Emerg Med 1997;4(3):214–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Chambers CT, Reid GJ, McGrath PJ, Finley GA. Self-administration of over-the-counter medication for pain among adolescents. Arch Pediatr Adolesc Med 1997;151(5):449–55.PubMedGoogle Scholar
  8. 8.
    Furu K, Skurtveit S, Rosvold EO. Self-reported medical drug use among 15–16 year-old adolescents in Norway (in Norwegian). Tidsskr Nor Laegeforen 2005;125(20):2759–61.PubMedGoogle Scholar
  9. 9.
    Nabors LA, Lehmkuhl HD, Parkins IS, Drury AM. Reading about over-the-counter medications. Issues Compr Pediatr Nurs 2004;27(4):297–305.PubMedCrossRefGoogle Scholar
  10. 10.
    Sansgiry SS, Cady PS. How the elderly and young adults differ in the decision making process of non-prescription medication purchases. Health Mark Q 1996;14(1):3–21.PubMedCrossRefGoogle Scholar
  11. 11.
    Westerlund LOT, Marklund BRG, Handl WHA, Thunberg ME, Allebeck P. Nonprescription drug-related problems and pharmacy interventions. Ann Pharmacother 2001;35:1343–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Statistiska Centralbyrån. Statistics Sweden. Sveriges befolkning efter kön och ålder 31/12/2006. Available at: http://www.scb.se/templates/tableOrChart____78315.asp (accessed 3 July 2007).
  13. 13.
    van Mil JWF, Westerlund LOT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38:859–67.PubMedCrossRefGoogle Scholar
  14. 14.
    Westerlund LOT, Björk HT. Pharmaceutical care in community pharmacies: practice and research in Sweden. Ann Pharmacother 2006;40:1162–69.PubMedCrossRefGoogle Scholar
  15. 15.
    Brener ND, Kann L, McManus T, Kinchen SA, Sundberg EC, Ross JG. Reliability of the 1999 youth risk behavior survey questionnaire. J Adolesc Health 2002;31(4):336–42.PubMedCrossRefGoogle Scholar
  16. 16.
    Vereecken CA, Maes L. A Belgian study on the reliability and relative validity of the health behaviour in school-aged children food-frequency questionnaire. Public Health Nutr 2003;6(6):581–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Stanton WR, McClelland M, Elwood C, Ferry D, Silva PA. Prevalence, reliability and bias of adolescents’ reports of smoking and quitting. Addiction 1996;91:1705–14.PubMedCrossRefGoogle Scholar
  18. 18.
    Andersen A, Kroelner R, Holstein BE, Due P, Hansen EH. Medicine use among 11- and 13-year olds: Agreement between parents’ reports and children’s self-reports. Ann Pharmacother 2007;41:581–6.PubMedCrossRefGoogle Scholar
  19. 19.
    Dunbar-Jacob J, Burke LE, Puczynski S. Clinical assessment, management of adherence to medical regimens. In: Nicassio M, Smith T, eds. Managing chronic illness: a biopsychosocial perspective. Washington DC: American Psychological Association; 1995. p. 313–41.CrossRefGoogle Scholar
  20. 20.
    Tobi H, Meijer WM, Tuinstra J, de Jong-van den Berg LT. Socio-economic differences in prescription and OTC drug use in Dutch adolescents. Pharm World Sci 2003;25(5):203–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Andersen A, Holstein BE, Hansen EH. Is medicine use in adolescence risk behaviour? Cross-sectional survey of school-aged children from 11 to 15. J Adolesc Health 2006;39(3):362–6.PubMedCrossRefGoogle Scholar
  22. 22.
    O’Connell K, Davis AR, Westhoff C. Self-treatment patterns among adolescent girls with dysmenorrhea. J Pediatr Adolesc Gynecol 2006;19(4):285–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Hurwitz Es. Reye’s syndrome. Epidemiol Rev 1989;11:249–53.PubMedGoogle Scholar
  24. 24.
    Orlowski JP, Hanhan UA, Fiallos MR. Is aspirin a cause of Reye’s syndrome? A case against. Drug Saf 2002;24(4):225–31.CrossRefGoogle Scholar
  25. 25.
    Westerlund T, Eriksson L, Larsson H. Drug advertising – a cause of drug-related problems? (poster). The 65th International Congress of FIP, Cairo, September 7–8, 2005. Available at: http://liddell.lbn.fr/fiche.php?action=view&tuple=505 (accessed 3 July 2007).
  26. 26.
    Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register – opportuntities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16(7):726–35.PubMedCrossRefGoogle Scholar
  27. 27.
    Statistics from the Swedish Prescribed Drug Register, Centre for Epidemiology, the National Board of Health and Welfare, Stockholm, personal communication with Mr Åke Karlsson, March 28, 2007.Google Scholar
  28. 28.
    Skurtveit S, Rosvold EO, Furu K. Use of psychotropic drugs in an urban adolescent population: the impact of health-related variables, lifestyle and sociodemographic factors – The Oslo Health Study 2000–2001. Pharmacoepidemiol Drug Saf 2005;14(4):277–83.PubMedCrossRefGoogle Scholar
  29. 29.
    Gunnarsson M, Ax F, Westerlund T, Brånstad J-O, Gustafsson S. Prevalence of drug-related problems (DRPs) among patients with prescriptions on NSAIDs using representatives to fetch their medicines at the pharmacy (poster). The 65th International Congress of FIP, Cairo, September 7–8, 2005. Available at: http://liddell.lbn.fr/fiche.php?action=view&tuple=506 (accessed 3 July 2007).
  30. 30.
    Westerlund T, Almarsdóttir AB, Melander A. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract 1999;7:40–50.Google Scholar
  31. 31.
    Statistics from the Swedish national DRP database SWE-DRP, Apoteket AB, Stockholm, personal communication with Ms Annika Forsén, April 2, 2007.Google Scholar
  32. 32.
    Kyngäs HA, Kroll T, Duffy ME. Compliance in adolescents with chronic diseases: a review. J Adolesc Health 2000;26:379–388.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Michael Westerlund
    • 1
  • Jan-Olof Brånstad
    • 2
  • Tommy Westerlund
    • 3
    • 4
    Email author
  1. 1.OlympiaskolanHelsingborgSweden
  2. 2.Apoteket ABStockholmSweden
  3. 3.Research and DevelopmentApoteket ABHelsingborg and StockholmSweden
  4. 4.Social Medicine, Department of Public Health and Community MedicineGöteborg UniversityGoteborgSweden

Personalised recommendations